<![CDATA[Background: Cervical cancer is the most common cancer and a main cause of death among women in low- and middle-income country. A simple screening method using Visual Inspection with Acetic Acid (VIA) has been recommended. However, the diagnostic accuracy of this test varies across populations and clinical contexts. Objective: To evaluate the diagnostic accuracy of VIA compared with the gold standard (histopathology) for detecting precancerous lesions in the cervix. Research Methods: A systematic search was conducted in PubMed, Scopus, and ScienceDirect from 2015 to 2025 following the PRISMA guidelines. A total of 764 studies were identified and only 15 studies were included, with a total sample of 3,237. The risk of bias was assessed using the QUADAS-2. Studies reporting diagnostic outcomes (TP, FP, TN, FN) were included in this review. The data were analysed using a bivariate random-effects model with HSROC curve. Results: The overall analysis showed a pooled sensitivity of 68% (95% CI: 55–80%) and a specificity of 79% (95% CI: 66–88%), indicating moderate diagnostic accuracy across studies. The HSROC curve was positioned toward the upper-left region, reflecting higher specificity and improved model stability. Subgroup analysis revealed that VIA in HIV-negative women demonstrated the best diagnostic performance sensitivity 78%, specificity 85%. When VIA was used as a primary test, it exhibited the most balanced accuracy sensitivity 75%, specificity 80% compared with VIA as a triage test. Conclusion: VIA test demonstrates moderate diagnostic accuracy for detecting cervical precancerous lesions, the best performing in HIV-negative populations, and when used as a primary test.]]>
Copyrights © 2025
